GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DNA Group (TR) Ltd (XTAE:DNA) » Definitions » YoY EBITDA Growth

DNA Group (TR) (XTAE:DNA) YoY EBITDA Growth : 25.00% (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is DNA Group (TR) YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. DNA Group (TR)'s YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 25.00%.

DNA Group (TR)'s EBITDA per Share for the six months ended in Jun. 2024 was ₪-0.01.


DNA Group (TR) YoY EBITDA Growth Historical Data

The historical data trend for DNA Group (TR)'s YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Group (TR) YoY EBITDA Growth Chart

DNA Group (TR) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -165.40 96.63 48.08 -81.48 63.27

DNA Group (TR) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.83 -66.67 73.33 50.00 25.00

DNA Group (TR) YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

DNA Group (TR)'s YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.018--0.049)/ | -0.049 |
=63.27 %

DNA Group (TR)'s YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(-0.006--0.008)/ | -0.008 |
=25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DNA Group (TR) YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of DNA Group (TR)'s YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Group (TR) Business Description

Traded in Other Exchanges
N/A
Address
Shimon Hatirsi Street 43, Tel Aviv, ISR, 62492
Website
DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.